European Journal of Pharmacology logo Elsevier logo

Publisher: Elsevier

Related content
Volume 427, Number 3, 21 September 2001

< previous issue | all issues | next issue >

Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis
pp. 175-185(11)
Authors: Oh C.-D.; Kim S.-J.; Ju J.-W.; Song W.K.; Kim J.-H.; Yoo Y.J.; Chun J.-S.

Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors
pp. 187-193(7)
Authors: Lidow M.S.; Roberts A.; Zhang L.; Koh P.-O.; Lezcano N.; Bergson C.

Inhibition by docosahexaenoic acid of receptor-mediated Ca2+ influx in rat vascular smooth muscle cells stimulated with 5-hydroxytryptamine
pp. 195-201(7)
Authors: Hirafuji M.; Ebihara T.; Kawahara F.; Hamaue N.; Endo T.; Minami M.

Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse
pp. 203-210(8)
Authors: Sakurada S.; Hayashi T.; Yuhki M.; Orito T.; Zadina J.E.; Kastin A.J.; Fujimura T.; Murayama K.; Sakurada C.; Sakurada T.; Narita M.; Suzuki T.; Tan-no K.; Tseng L.F.

The effects of endothelin-1 on ischaemia-induced ventricular arrhythmias in rat isolated hearts
pp. 235-242(8)
Authors: Sharif I.; Crockett T.R.; Kane K.A.; Wainwright C.L.

Diabetes abolishes the gender difference in vasopressin-mediated potentiation of sympathetic vasoconstriction
pp. 243-250(8)
Authors: Sanz E.; Monge L.; Fernandez N.; Martnez M.A.; Dieguez G.; Garca-Villalon A.L.

Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed
pp. 251-262(12)
Authors: Mendizabal V.E.; Orliac M.L.; Adler-Graschinsky E.

Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves
pp. 263-276(14)
Authors: Pajdo R.; Brzozowski T.; Konturek P.C.; Kwiecien S.; Konturek S.J.; Sliwowski Z.; Pawlik M.; Ptak A.; Drozdowicz D.; Hahn E.G.

High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists
pp. 285-293(9)
Authors: Wang P.-R.; Guo Q.; Ippolito M.; Wu M.; Milot D.; Ventre J.; Doebber T.; Wright S.D.; Chao Y.-S.

Author index
pp. 295-297(3)

Keyword index
pp. 299-304(6)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page